Although only 10% of the shares were left to him, compared to the astronomical wealth that new anti-cancer drugs will create in the future, the benefits represented by this 10% are also extremely astonishing.
If it were anyone else, they would either disagree, the drug is stuck by the Food and Drug Administration, and have been unable to pass review, billions of R&D funds have been wasted, and they cannot recover a penny of the cost, or they will give up most of the money.
He gave up some of his interests and retained the 10% of the shares, which was enough for him to make a lot of money. I believe that the vast majority of people would choose to give in when faced with this situation!
But this naturally does not include Chen Mo. Let alone 90%, Chen Mo will not give up even 1% of his shares!
You're playing this trick with me, you're looking for the wrong person!
Chen Moquan clearly heard the content of the call just now. Although the CEO of Merck Pharmaceutical Group did not say a word of threat, combined with the fact that their drug review was just blocked by the Food and Drug Administration, this call
In fact, it is a threat!
Either cooperate and give up most of the benefits, or you will be completely stuck and will not be able to get back a penny!
The fact that the other party can change the face of the Food and Drug Administration and block them is enough to show their strong strength. They naturally have the confidence to deal with the counterattack of the Aegis creatures.
The Food and Drug Administration did not violate any regulations, they just acted according to the rules. At most, it can be said that they are a bit rigid, and their starting point is still for drug safety!
Even if it makes a fuss in the media, it will not have any impact on them. They still need to conduct long-term clinical trials in accordance with regulations and then wait for further review.
At that time, they can continue to delay for various reasons. As long as Chen Mo does not compromise, the Aegis creature will be completely blocked!
Chen Mo is almost certain that there is probably more than just a pharmaceutical company behind this matter, Merck Pharmaceuticals!
But will Chen Mo be threatened?
This may be the only thing they missed!
"Send people to contact the health departments of China, Europe and other countries, and tell them that we intend to open branches in their countries, build pharmaceutical factories, and put this new anti-cancer drug on the market first in their countries!"
Chen Mo said calmly.
Su Wan's eyes lit up when she heard this, why didn't she think of it?
Generally, new drugs developed by pharmaceutical companies will first pass the review in their own country, and then enter other countries. The re-review process will be much simpler. Almost no one will go to other countries for the initial review of drugs.
But this is a good idea for them. Since the Food and Drug Administration of the United States has blocked their new anti-cancer drugs, they can go to other countries for review, even if the United States does not recognize other countries by then.
As a result of the review, the worst possible outcome is to give up the US market. The world is so big, but it’s not like we can’t survive without the US!
When their new anti-cancer drugs are first launched in other countries and see actual results, I wonder if these officials from the Food and Drug Administration will be drowned in the saliva of the American people!
As for people in the United States having no way to receive treatment, don’t forget that Su Wan and Chen Mo are both Chinese!
If you have good things, of course you should stick with your compatriots first. If your own country’s officials seek death, there’s nothing we can do about it!
The previous review in the United States was just for convenience. Once the review is passed, neither Su Wan nor Chen Mo will forget their Chinese compatriots and will inevitably put this drug on the Chinese market at the same time.
The current situation requires them to conduct reviews in various countries again. Although it may lead to delays in the launch of drugs, China must still be their primary target. As for the United States, which could have been the first batch of beneficiary countries together with China, it is very likely that it will become the world's first beneficiary country.
The last country to launch new anti-cancer drugs!
Suddenly enlightened, Su Wandang began to contact the health departments of China, Europe and other countries, expressing her willingness to open branches and conduct drug reviews in various countries.
When all countries received the news, they were all very surprised. Yes, it was a surprise!
Aegis Biotech's new anti-cancer drug has already been known to countries around the world through previous reports by major media in the United States. Health departments in various countries have attached great importance to this kind of drug that has the potential to completely cure cancer, and they have also sent people to investigate this kind of drug.
We have investigated the clinical trials of new anti-cancer drugs and found that the media did not exaggerate and Aegis Biotech did not falsify.
Comparing the before and after condition analysis and examination results of these cancer patients, the effect of the drug is clear at a glance. It has indeed inhibited the proliferation and spread of cancer cells. The condition of all patients participating in the trial has been greatly improved. This is for most of these late-stage cancers.
It is unthinkable that a patient may die at any time!
However, according to normal circumstances, this kind of drug will definitely pass the review first in the United States and obtain the license before being put on the world market. They just want to contact Shenshi Technology to introduce this drug into the country as soon as possible after the drug passes the review.
.
As for allowing Aegis Biotech to conduct drug review in their country, there has never been such a precedent before.
This is just like taking a driver's license test. Who would drive to another place after taking the driver's license test in their hometown, school or company location?
But now Aegis creatures do just that!
Therefore, after receiving the request from Aegis Biotech to build a branch in their own country and conduct drug review, all countries were pleasantly surprised, because this also meant that this new anti-cancer drug would be the first to be put into use in their country!
Moreover, Aegis Biotech not only sets up branches, but also builds factories in various countries. This means that this kind of medicine will be made domestically from imports, avoiding high import and export tariffs, and the final selling price will be much cheaper.
!
In addition to tangible benefits for cancer patients in this country, this is also a huge political achievement for them!
They had no reason to refuse. On the contrary, they were all enthusiastic and offered various preferential policies in the hope that Aegis Biotech could be the first to build a factory and launch it on the market in their country.
Other countries that Su Wan had no contact with, such as India, Japan, Australia and other countries, after receiving the news, also took the initiative to contact Aegis Biotech and sent invitations one after another, hoping that Aegis Biotech could establish branches in their countries and promised
Simplify the drug review process.
However, in fact, this kind of review does not need to be conducted in every country. As long as one country issues a drug license, the review in other countries will be much easier. (To be continued)